z-logo
open-access-imgOpen Access
Where will non-Vitamin K oral anticoagulants stand beyond being standard of care in anticoagulation therapy?
Author(s) -
Oktay Ergene
Publication year - 2019
Publication title -
international journal of the cardiovascular academy
Language(s) - English
Resource type - Journals
eISSN - 2618-6012
pISSN - 2405-8181
DOI - 10.4103/ijca.ijca_14_19
Subject(s) - medicine , warfarin , atrial fibrillation , stroke (engine) , deep vein , edoxaban , population , thrombosis , randomized controlled trial , intensive care medicine , rivaroxaban , mechanical engineering , environmental health , engineering

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom